Real-time enrollment status for this metastatic castration-resistant prostate cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 11:46 PM UTC
| NCT Number | NCT06922318 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration-resistant Prostate Cancer |
| Phase | PHASE2 |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
| Last Updated on CT.gov | June 18, 2026 (Jun 18, 2026) |
As of July 18, 2026: Clinical trial NCT06922318 is currently recruiting participants. This phase2 study for metastatic castration-resistant prostate cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06922318 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06922318 was last updated Jun 18, 2026 (June 18, 2026). HelloStudys verifies this status automatically.